Hypertension
📧 Sign up to get email alerts when something new happens for Hypertension.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2016-06-13FDA Approved: METOPROLOL SUCCINATE — Supplemental Application (Mylan Pharmaceuticals Inc.)
FDA approved a supplemental application for metoprolol succinate (generic) from Mylan Pharmaceuticals Inc., resulting in labeling changes as…
-
FDA approval · 2016-06-10FDA Approved: BENICAR — Supplemental Application (Cosette Pharmaceuticals, Inc.)
FDA approved Cosette Pharmaceuticals' supplemental application for BENICAR (olmesartan medoxomil), resulting in labeling updates for the pro…
-
FDA approval · 2016-06-10FDA Approved: LOSARTAN POTASSIUM — Supplemental Application (Alembic Pharmaceuticals Limited)
The FDA approved a supplemental application for losartan potassium submitted by Alembic Pharmaceuticals Limited (ANDA 090428). This action u…
-
FDA approval · 2016-06-10FDA Approved: LOSARTAN POTASSIUM TABLETS, 25 MG — Supplemental Application (Jubilant Cadista Pharmaceuticals Inc.)
FDA approved Jubilant Cadista Pharmaceuticals Inc. to market Losartan potassium tablets, 25 mg, as a generic product under an ANDA supplemen…
-
FDA approval · 2016-06-10FDA Approved: LOSARTAN POTASSIUM — Supplemental Application (Camber Pharmaceuticals, Inc.)
FDA approves Camber Pharmaceuticals' supplemental application for losartan potassium (generic), confirming an approved generic product.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2016-06-10Clinical Trial Update: Adherence Enhancement for Renal Transplant Patients [NA]
This clinical trial update reports completion of a study evaluating adherence-enhancement strategies for renal transplant patients (NCT01859…
-
CLINICAL_TRIALS research · 2016-06-10Clinical Trial Update: Measurement of Endothelial Function and Cardiac Output: New Methods
This report describes a completed clinical trial focused on new methods to measure endothelial function and cardiac output.
-
FDA approval · 2016-06-09FDA Approved: LOSARTAN POTASSIUM — Supplemental Application (Lupin Pharmaceuticals, Inc.)
FDA approved a supplemental application for Losartan Potassium (generic) from Lupin Pharmaceuticals, Inc.
-
FDA approval · 2016-06-09FDA Approved: LOSARTAN POTASSIUM — Supplemental Application (Micro Labs Limited)
FDA approved a supplemental application for Losartan Potassium from Micro Labs Limited, granting a supplemental approval for this generic pr…
-
FDA approval · 2016-06-09FDA Approved: DOXAZOSIN — Supplemental Application (Mylan Pharmaceuticals Inc.)
FDA approved a supplemental application for doxazosin from Mylan Pharmaceuticals, indicating a labeling or formulation update to the existin…
-
FDA approval · 2016-06-09FDA Approved: LOSARTAN POTASSIUM — Supplemental Application (Macleods Pharmaceuticals Limited)
FDA approved a supplemental application for Losartan Potassium from Macleods Pharmaceuticals Limited under ANDA 202230, enabling marketing o…
-
CLINICAL_TRIALS trial_result · 2016-06-08Clinical Trial Update: Study of the Relationship Between Blood Vessels and Insulin Response in Adolescents
A completed clinical trial explored the relationship between blood vessel function and insulin response in adolescents, including subjects w…
-
CLINICAL_TRIALS research · 2016-06-07Clinical Trial Update: Diet Intervention and GEnetic STudy (DIGEST-Pilot) [NA]
A DIGEST-Pilot clinical trial update describes a diet intervention with genetic aspects aimed at cardiovascular risk factors; current status…
-
FDA approval · 2016-06-03FDA Approved: BENAZEPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE — Supplemental Application (Padagis US LLC)
The FDA approved a supplemental application for the combination drug benazepril hydrochloride and hydrochlorothiazide submitted by Padagis U…
-
CLINICAL_TRIALS research · 2016-06-03Clinical Trial Update: DP-R212 Pharmacokinetic Study [Phase 1]
Phase 1 pharmacokinetic study of DP-R212 sponsored by Alvogen Korea. It targets hypertension and hyperlipidemia; current trial status is unk…
-
CLINICAL_TRIALS trial_result · 2016-06-01Clinical Trial Update: Congenital Malformations and Maternal Use of Anti-hypertensive Medication in the United Kingdom
This completed UK clinical trial, sponsored by AstraZeneca, evaluated potential congenital malformations in offspring associated with matern…
-
CLINICAL_TRIALS trial_result · 2016-06-01Clinical Trial Update: Influence of Sodium Intake on Left Ventricular-arterial Coupling [NA]
A terminated clinical trial from University Hospital, Montpellier investigated how sodium intake affects left ventricular-arterial coupling …
-
CLINICAL_TRIALS trial_result · 2016-05-27Clinical Trial Update: Effects of Vitamin D on Renin Expression in Hypertensive Patients [EARLY_Phase 1]
A Phase 1 trial investigating the effect of vitamin D on renin expression in hypertensive patients was terminated; results are not detailed …
-
FDA approval · 2016-05-24FDA Approved: ENALAPRIL MALEATE AND HYDROCHLOROTHIAZIDE — Supplemental Application (Taro Pharmaceuticals U.S.A., Inc.)
The FDA approved a supplemental application for Enalapril Maleate and Hydrochlorothiazide from Taro Pharmaceuticals U.S.A., Inc. This supple…
-
CLINICAL_TRIALS research · 2016-05-24Clinical Trial Update: Prospective Characterization of the Heart, Aorta and Blood Pressure in Turner Syndrome. Association With Aortic Dissection.
This clinical trial update describes a prospective study of heart, aorta, and blood pressure in individuals with Turner syndrome to investig…
-
CLINICAL_TRIALS withdrawal · 2016-05-23Clinical Trial Update: Renal Denervation in Treatment Resistant Hypertension [Phase 3]
Phase 3 trial evaluating renal denervation for treatment-resistant hypertension was terminated.
-
CLINICAL_TRIALS trial_result · 2016-05-23Clinical Trial Update: Effect of Lettuce With Different Nitrate Contents on Blood Pressure [Phase 1, Phase 2]
A Phase 1/2 clinical trial from Newcastle University tests whether lettuce with different nitrate contents can influence blood pressure, exp…
-
FDA approval · 2016-05-20FDA Approved: NISOLDIPINE — Supplemental Application (Prasco Laboratories)
FDA approved a supplemental application for nisoldipine by Prasco Laboratories.
-
CLINICAL_TRIALS trial_result · 2016-05-18Clinical Trial Update: AVE7688 in Patients With Mild to Moderate Blood Pressure [Phase 2, Phase 3]
Reports the completion of Phase 2 and Phase 3 clinical trials of AVE7688 in patients with hypertension. Sponsored by Sanofi.
-
CLINICAL_TRIALS trial_result · 2016-05-18Clinical Trial Update: Eplerenone in Heart Failure Treatment
A clinical trial evaluating eplerenone for heart failure treatment has completed, with indications including heart failure, acute myocardial…